How to Choose a Peptide Supplier

Almost every listing in this category carries a number like ≥99%. On its own that number means very little, because purity is not a property of a molecule — it is the output of a specific measurement. A purity figure is only interpretable when three things travel with it: the method, the detection wavelength or detector type, and the batch it was measured on.

The near-universal method is analytical reversed-phase HPLC with UV detection, usually at 214 nm (which sees the peptide backbone's amide bonds) or 220 nm. The reported figure is an area-percent: the area under the main chromatographic peak divided by the total area of all integrated peaks, times one hundred. That definition carries two consequences most buyers never consider.

First, area-percent is relative. It tells you how much of what the detector saw was the main peak. It says nothing about material the detector could not see — inorganic salts, residual solvent, and water all have little or no absorbance at 214 nm and are simply invisible to the measurement. Second, area-percent is sensitive to how the chromatographic run was set up. A short gradient over a narrow solvent range will co-elute impurities under the main peak and inflate the number; a long, shallow gradient resolves them and lowers it. The same material can honestly report 97% and 99.5% depending on the method.

So the question to ask is not "what is the purity?" It is "purity by what method, at what wavelength, on which lot?" A supplier who can answer that is measuring something. A supplier whose only answer is the number on the product page is repeating a marketing figure. See peptide purity vs. net peptide content for the separate and frequently conflated question of how much peptide is actually in the vial.

A certificate of analysis is a record that a described set of tests was run on a described lot of material and produced described results. That is genuinely useful. It is also narrower than most buyers assume.

A COA proves: that a sample was analysed, what methods were used, what the instrument reported, and — if it is properly issued — which lot the sample came from and who signed for the result.

A COA does not prove: that the sample analysed came from the same container that shipped to you. It does not prove the material was stored correctly between analysis and dispatch. It does not prove anything about lots other than the one named on the document. And a COA showing only a chromatogram does not establish identity at all — chromatography separates, it does not identify. Confirming that the dominant peak is the intended sequence requires mass spectrometry, which is a different measurement answering a different question. That distinction is worth understanding before you read another COA; HPLC vs. mass spectrometry covers it in full, and how to read a peptide COA walks the document section by section.

The practical upshot: read a COA as evidence about a lot, not as a warranty about a supplier. Its value scales with how specific and how traceable it is.

This is the single sharpest discriminator available to a buyer, and it costs nothing to check.

Peptide synthesis is a multi-step process whose yield and impurity profile vary between runs. Two lots of the same sequence, made by the same laboratory, will not produce identical chromatograms. It follows that a genuine analytical record is per lot and looks different each time.

Batch-specific documentation carries a lot or batch identifier that matches a label on the physical container, a date of analysis, the sequence and molecular formula as tested, and a chromatogram whose retention times and peak shapes are particular to that run. You can cross-reference the lot number on the vial against the lot number on the document, and they either agree or they do not.

Generic documentation has none of that anchoring. The tells are consistent: the same image appears against every strength of the same compound; the analysis date is old or missing; the lot field is blank, reads "typical", or carries a placeholder; or the chromatogram is a low-resolution screenshot with the axes cropped off. A representative or illustrative trace is not evidence about the material you are buying. It is a picture of some material, once.

Ask directly: can you send the COA for the lot you would actually ship me? The answer to that question separates suppliers more cleanly than any other question on this page.

None of these is proof of anything on its own. Two or three together are a pattern.

• No lot numbers anywhere. Not on the vial, not on the paperwork, not in the order confirmation. Without a lot identifier there is no traceability, no way to raise a specific complaint, and no way for the supplier to recall or investigate a bad run even if it wanted to.
• Stock or reused COA images. Reverse-image-search a COA graphic occasionally; the results are instructive. Watch for identical traces across different compounds, visible compression artefacts, and analysis dates that never change.
• Effect claims in product copy. A listing for a research chemical that describes what the compound does to a person is a listing written by a marketing team, not a chemistry team. It is also the specific thing regulators cite. A supplier willing to write that copy has already told you how it weighs commercial pressure against compliance, and that judgement will apply to its sourcing decisions too.
• Independent testing that leaves no trace on the paperwork. Where analysis is described as third-party, the certificate itself should carry the testing organisation's name, letterhead and contact details. A claim of independence that never appears on the document it supposedly describes is a word, not a fact.
• Purity figures with no method and no variation. A catalogue where every single compound is exactly 99.4% is reporting a house style, not a set of measurements. Real analytical results scatter.
• Vague or missing corporate identity. No registered entity, no physical address, no named contact, support that exists only as a web form.

Analytical quality established at the synthesis laboratory can be degraded by everything that happens afterwards, and that part of the chain is entirely the supplier's to manage.

Lyophilised peptide is comparatively robust — that is the point of freeze-drying — but it is robust, not indestructible. What matters in transit is protection from moisture ingress and from sustained heat. Reasonable questions: are vials sealed with an intact crimp and stopper? Is the headspace inert, or at least dry? Is the outer packaging opaque? For material the supplier itself describes as cold-stored, is it dispatched with a cold pack, and how long is the carrier transit?

Ask how the supplier stores stock before it ships, not only how it recommends you store it after it arrives. A supplier that publishes handling guidance for its own warehouse is telling you it has thought about the problem. For the receiving end of that chain, see peptide storage and handling.

It is tempting to read a supplier's legal language as boilerplate to be skipped. Read it instead as a statement of what the supplier believes it is selling.

A coherent posture looks like this: the material is described as a research chemical throughout, in the same terms on the product page as in the footer; no listing describes an outcome in a person or an animal; there is no guidance on administration anywhere on the site; the classification restrictions are stated plainly rather than buried; and the disclaimer at the bottom of the page does not contradict the sales copy at the top of it.

That last point deserves emphasis, because it is where most of this category fails. A research-use-only notice in the footer does not neutralise copy elsewhere on the same page that describes what a compound does in a body. Regulators read the whole page. So should you — a site whose disclaimers and sales copy are in open contradiction is a site that either does not understand its own obligations or has decided to ignore them. Research use only, explained sets out what the classification means and what it asks of a buyer.

Condensed, in the order worth asking:

• Purity by what method, at what detection wavelength?
• Can I see the certificate of analysis for the lot you would ship?
• Does the vial carry a lot number that matches that document?
• Is identity confirmed by mass spectrometry, or is purity the only measurement?
• Is net peptide content reported separately from chromatographic purity?
• What is the salt form, and is the stated quantity gross or peptide-corrected?
• How is stock stored before dispatch, and how is it packed?
• Is there a registered entity, a physical address, and a named human to contact?
• Does any page on the site describe an effect in a person or an animal?

A supplier that answers most of these is measuring, recording, and standing behind its material. One that deflects most of them is reselling. Both exist in this market, and the difference is visible before you order — if you ask.

• How to Read a Peptide Certificate of Analysis
• Peptide Purity vs. Net Peptide Content
• Research Use Only, Explained
• Peptide Storage and Handling
• Shop Research Peptides